A survey of strategic licensing practices in the pharmaceutical industry

A survey of strategic licensing practices in the pharmaceutical industry
Alliances often appear to be a relatively cost-effective and rapid answer to fill dwindling pharmaceutical company pipelines; however, studies suggest that over half of all alliances fail to achieve their intended outcomes. This survey has, therefore, been carried out to understand the key strategic and operational challenges associated with the in- and out-licensing process and to provide some insight into improving the situation.

Biotechblog
Scroll to Top